Hormona Funding News – London-Based HealthTech Startup Hormona Raises €7.8 Million

The company uses AI and testing to help women track, understand, and optimize their hormone health.

The round was led by Voima Ventures (Helsinki) and co-led by SuperNode Global VC (London), with support from DLF Ventures and existing investors Nascent Invest (Sweden) and Techstars (US).

Hormona CEO and Co-founder Karolina Löfqvist comments: “For too long, women have had to suffer through hormonal issues, relying on trial and error and waiting until symptoms become unbearable. That’s no way to live. We built Hormona to change that – to give women control over their hormonal health without having to spend years suffering, as I did. This investment brings us one step closer to making real-time hormone tracking accessible to women everywhere without the need for multiple blood draws. We’re proud to be leading the way and improving women’s health, one user at a time.”

Hormona works with endocrinologists, gynecologists, and nutritionists to provide expert, science-based insights. With a 12-member team, the company has raised €10.2 million in total funding.

Read Also - Finnish MedTech Startup Surgify Medical Secures €7M To Make Bone Surgery Safer

It was built alongside medical experts to help users manage hormone-related issues and better understand their overall health.

Hormona was inspired by CEO Karolina Löfqvist’s personal journey. She struggled for years with an undiagnosed hormonal condition that affected her daily life, despite seeing many doctors. The company says her story is common—80% of women face hormone-related health issues.

Inka Mero, Managing Partner and Founder at Voima Ventures adds: “At Voima Ventures, we seek out visionary teams and bold science that can redefine entire industries, and Hormona is exactly that: they are pioneering a global movement in women’s health. By tackling one of the most overlooked yet fundamental aspects of women’s well-being – hormonal health – they are giving millions of women the tools, data, and empowerment to take control of their bodies and lives. We are incredibly proud to stand beside Hormona as they lead this health revolution.”

Over the past four years, Hormona has developed the first fully quantitative at-home hormone tests, covering the full clinical range.

These tests are over 90% as accurate as traditional blood tests, making hormone tracking more accessible than ever.

In addition to the tests, Hormona’s app helps women learn about hormonal health. It has been downloaded in over 190 countries and is growing quickly, with 30% month-over-month user growth and 80% of users staying active after 12 months.

Gina King, Partner at SuperNode Global VC comments: “The future of women’s health is proactive, data-driven, and deeply personalised – and Hormona is making that future a reality. They’re bringing cutting-edge innovation to an area long overlooked by investment and technology, turning hormone health from guesswork into precision. At Supernode Global, we invest in companies that empower people in how they live – and Hormona exemplifies that mission. By providing women with insights that were once out of reach, Hormona is transforming the landscape of healthcare. They represent exactly the kind of world-changing platform we’re proud to support as they scale globally and help millions of women live to their fullest potential.”

Hormona believes women’s health is still overlooked and underfunded. Only 2% of global medical research funding goes to women-specific health issues.

In the UK, all-female founder teams received just 2% of total equity investment last year—down from 2.5% in 2023.

Hormona aims to close this gender health gap. While traditional hormone tests can cost around €177 for a single test, Hormona offers affordable, ongoing tracking without needing a lab. This helps address the fact that women spend 25% more of their lives in poor health than men.

The Hormona app is free to download on iOS and Android. Its premium version, Hormona+, offers personalized cycle predictions, health programs, lifestyle tips, symptom reduction plans, and supplements.

Users can also invite partners to receive email updates with insights and tips tailored to each phase of the cycle.

To support its next growth phase, Inka Mero (Voima Ventures) and Gina King (SuperNode) will join Hormona’s all-female board.

About Hormona

Founded in 2020, Hormona is a women’s health startup that uses AI and at-home testing to help women better understand and manage their hormone health. Co-founded by Karolina Löfqvist (CEO) and Jasmine Tagesson (COO), the platform offers personalized hormone tracking and expert guidance to support women in dealing with hormonal imbalances and related health issues.